Answers are grounded in this paper and cite their sources.
A new generation of medications for obesity could transform the global food system. While research has explored their health impacts, their implications for global food demand and land use remain unquantified. We apply a global food system model to project the impact of glucagon-like peptide-1 receptor agonist (GLP-1) uptake to 2050 among people with obesity under two scenarios: reduced calorie intake while maintaining dietary composition, and reduced calorie intake combined with shifts towards the EAT–Lancet diet. Compared with the Reference scenario, GLP-1-mediated calorie reduction alone results in up to 6.6 million avoided deaths globally in 2050 and 32 Mha more natural land area, reflecting reductions in cropland, pasture and managed forest. Combining GLP-1 use with EAT–Lancet dietary shifts increases these estimates to 7.7 million avoided deaths and 46 Mha more natural land. Lower food prices increase food consumption among untreated populations, including unhealthy foods, partially offsetting these gains.
No takes yet. Share an insight, caveat, or question.
Henry et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: